Merck & Co. Inc. buy Citigroup Inc.
Start price
25.10.24
/
50%
€96.70
Target price
25.10.25
€120.32
Performance (%)
-21.92%
End price
26.10.25
€75.50
Summary
This prediction ended on 26.10.25 with a price of €75.50. The price of Merck & Co. Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.92%. Citigroup_Inc_ has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. A total of €1.58 was paid as dividends for this prediction. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 2.181% | 2.181% | -3.302% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
Comments by Citigroup_Inc_ for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Citigroup Inc. from $140.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten